skip to content

BioNTech

BIONTECH NEWS

Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents

December 06, 2022 11:19 am

A Pfizer spokesperson said the company and BioNTech are confident in their intellectual property and will "vigorously defend" against Moderna's claims.

BioNTech expects Omicron-adapted vaccine deliveries as soon as October

August 08, 2022 6:53 pm

Partner Pfizer at the end of last month forecast $32 billion in full-year COVID-19 vaccine sales.

‘Vaccines give extra protection to those with immunity from previous Covid infection’

April 01, 2022 11:44 am

Participants were selected from national disease surveillance and vaccination databases if they had a PCR confirmed SARS-CoV-2 reinfection, at least 90 days after they contracted the initial infection (22,566 people in total).

Pfizer-BioNTech seek US OK for second COVID booster for 65 and older

March 16, 2022 6:44 pm

Pfizer-BioNTech filed an application with US regulators seeking emergency use authorization for a second booster shot of their Covid-19 vaccine for people aged 65 and older.

US considers lengthening gap between first 2 Covid shots to 8 weeks

February 05, 2022 1:52 pm

In the United States, the recommended interval between the first two shots of Pfizer's vaccine is three weeks and for Moderna's, four.

Pfizer vaccine for children under 5 may be available in US by February end, says report

February 01, 2022 1:54 pm

Coronavirus vaccines for children younger than 5 could be available as soon as end-February under a plan that would lead to the potential authorisation of a two-shot regimen in the coming weeks.

Israel begins administering 4th vaccine dose

December 31, 2021 10:01 pm

The country will administer a fourth dose of the vaccine to individuals with weakened immune systems, along with elderly residents and employees in care homes.

Explained: What scientists have found about a class of antibodies that can neutralise the Omicron variant

December 30, 2021 7:58 pm

The antibodies identified by the scientists target areas of the virus spike protein that remain unchanged as it mutates.

Hong Kong researchers urge third Covid-19 shot after new Omicron study

December 15, 2021 11:28 am

This comes after a study showed insufficient antibodies were generated by the Sinovac and BioNTech products to fend off Omicron.

BioNTech starts work on Omicron-specific vaccine

November 29, 2021 8:19 pm

The development of an adapted vaccine is part of the company's standard procedure for new variants, BioNTech, which makes vaccines together with Pfizer, said in a statement.

Advertisement
Advertisement
Advertisement
Edition
Install the Express App for
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us